NEW ERA HELIUM INC (NEHC) Fundamental Analysis & Valuation

NASDAQ:NEHC • US64428N1090

Current stock price

0.457 USD
+0.07 (+19.32%)
At close:
0.4515 USD
-0.01 (-1.2%)
After Hours:

This NEHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NEHC Profitability Analysis

1.1 Basic Checks

  • In the past year NEHC has reported negative net income.
  • In the past year NEHC has reported a negative cash flow from operations.
  • In multiple years NEHC reported negative net income over the last 5 years.
  • In the past 5 years NEHC always reported negative operating cash flow.
NEHC Yearly Net Income VS EBIT VS OCF VS FCFNEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA -159.89%
ROE N/A
ROIC N/A
ROA(3y)-49.78%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NEHC Yearly ROA, ROE, ROICNEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NEHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NEHC Yearly Profit, Operating, Gross MarginsNEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. NEHC Health Analysis

2.1 Basic Checks

  • NEHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NEHC has about the same amount of shares outstanding.
  • NEHC has a worse debt/assets ratio than last year.
NEHC Yearly Shares OutstandingNEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M
NEHC Yearly Total Debt VS Total AssetsNEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -6.91, we must say that NEHC is in the distress zone and has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.91
ROIC/WACCN/A
WACC8.5%
NEHC Yearly LT Debt VS Equity VS FCFNEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • NEHC has a Current Ratio of 0.51. This is a bad value and indicates that NEHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NEHC has a Quick Ratio of 0.51. This is a bad value and indicates that NEHC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
NEHC Yearly Current Assets VS Current LiabilitesNEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. NEHC Growth Analysis

3.1 Past

  • NEHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -668.19%.
  • The Revenue for NEHC has decreased by -12.97% in the past year. This is quite bad
EPS 1Y (TTM)-668.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-873.58%
Revenue 1Y (TTM)-12.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NEHC Yearly Revenue VS EstimatesNEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 200K 400K 600K

More info and screens

Find the best growth stocksShow best growing peers

0

4. NEHC Valuation Analysis

4.1 Price/Earnings Ratio

  • NEHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEHC Price Earnings VS Forward Price EarningsNEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEHC Per share dataNEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NEHC Dividend Analysis

5.1 Amount

  • No dividends for NEHC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NEHC Fundamentals: All Metrics, Ratios and Statistics

NEW ERA HELIUM INC

NASDAQ:NEHC (8/12/2025, 8:06:29 PM)

After market: 0.4515 -0.01 (-1.2%)

0.457

+0.07 (+19.32%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners26.95%
Inst Owner Change358.91%
Ins Owners34.4%
Ins Owner ChangeN/A
Market Cap6.02M
Revenue(TTM)509.60K
Net Income(TTM)-15.87M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.81
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.3
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0.04
BVpS-0.21
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -159.89%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-49.78%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z -6.91
F-Score3
WACC8.5%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-668.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-873.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-605.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-811.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-688.11%
OCF growth 3YN/A
OCF growth 5YN/A

NEW ERA HELIUM INC / NEHC Fundamental Analysis FAQ

What is the fundamental rating for NEHC stock?

ChartMill assigns a fundamental rating of 0 / 10 to NEHC.


What is the valuation status for NEHC stock?

ChartMill assigns a valuation rating of 0 / 10 to NEW ERA HELIUM INC (NEHC). This can be considered as Overvalued.


How profitable is NEW ERA HELIUM INC (NEHC) stock?

NEW ERA HELIUM INC (NEHC) has a profitability rating of 0 / 10.


How financially healthy is NEW ERA HELIUM INC?

The financial health rating of NEW ERA HELIUM INC (NEHC) is 0 / 10.